Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EVI Industries, Inc. | 2YE | Nov 18, 2024 | 16.20 | -2.41 |
EVION GROUP NL | BAPA | Nov 18, 2024 | 0.02 | 0.00 |
Eviso SPA | 6Z8 | Nov 18, 2024 | 6.10 | +1.33 |
EVLI OYJ B | V6O | Nov 18, 2024 | 17.90 | -0.83 |
EVN AG | EVN | Nov 18, 2024 | 25.05 | -0.99 |
Evolent Health, Inc Class A | 9EH | Nov 18, 2024 | 11.70 | -2.50 |
Evolus, Inc. | EVL | Nov 18, 2024 | 11.40 | +2.70 |
Evolution | E3G1 | Nov 18, 2024 | 85.12 | -1.32 |
Evolution Energy Minerals Ltd | P77 | Nov 18, 2024 | 0.02 | +52.17 |
Evolution Mining Limited | WE7 | Nov 18, 2024 | 2.89 | +3.07 |
Evolution Petroleum Corporation, Inc. | EP7 | Nov 18, 2024 | 5.50 | 0.00 |
EVONIK INDS AG American Depositary Receipts - Unsponsored ( | EVKA | Nov 18, 2024 | 8.60 | +1.18 |
Evonik Industries AG | EVK | Nov 18, 2024 | 17.68 | -1.06 |
Evotec SE | EVT | Nov 18, 2024 | 10.36 | -0.19 |
EVOTEC SE ADR/2 O.N. | EVTA | Nov 18, 2024 | 5.05 | -1.94 |
EVS Broadcast Equipment SA | 5E1 | Nov 18, 2024 | 28.35 | +3.09 |
Exact Sciences Corporation | EXK | Nov 18, 2024 | 47.00 | -2.47 |
EXACT Therapeutics | 56F | Nov 18, 2024 | 0.49 | +0.41 |
Exagen Inc. | E08A | Nov 18, 2024 | 2.78 | +3.73 |
EXASOL AG NA O.N. | EXL | Nov 18, 2024 | 2.33 | +2.64 |
Excellence SA | 8XY | Nov 18, 2024 | 0.03 | -7.89 |
Excellon Resources Inc | E4X2 | Nov 18, 2024 | 0.06 | 0.00 |
Excelsior Mining Corp | 3XS | Nov 18, 2024 | 0.08 | 0.00 |
Exchange Income Corp | 0ON | Nov 18, 2024 | 37.20 | -1.06 |
Exclusive Networks SA | 97K | Nov 18, 2024 | 23.75 | +0.64 |
EXCO Technologies Ltd. | 3XT | Nov 18, 2024 | 5.65 | +0.89 |
Exedy Corporation | 64M | Nov 18, 2024 | 24.80 | -0.80 |
EXEL COMPOSITES OYJ | 8TY | Nov 18, 2024 | 0.27 | -0.74 |
Exel Industries | 8YK | Nov 18, 2024 | 44.50 | +1.83 |
Exelixis, Inc. | EX9 | Nov 18, 2024 | 32.42 | -1.07 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.